Expert Presents Significant Body Of Data From Randomized Controlled Trials Of EndoGastric Solutions, Inc.’ Transoral Incisionless Fundoplication (TIF) Procedure For GERD At SAGES 2015

SAN MATEO, Calif.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced that Karim Trad, MD, presented a review of data from EndoGastric Solutions’ multi-center, randomized, controlled TEMPO and RESPECT studies for the TIF procedure at SAGES 2015, the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons. SAGES runs from April 15 to 18, 2015 in Nashville.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC